Russell Lewis

19PUBLICATIONS
58CO-AUTHORS
Medical infection agents (incl. prions)Medical mycologyMolecular medicineMedical parasitologyToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 21, 2026
Does the Evidence Support High-Dose Liposomal Amphotericin B in the Treatment of Mucormycosis?

|Feb 06, 2026
Primary Therapy for Invasive Aspergillosis With Triazoles or L-AmB: A Multicenter Retrospective Study.

Matteo Rinaldi, Russell Edward Lewis, Maria Chiara Susini

|Nov 14, 2024
The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometrics.

David Andes, Roger J Brüggemann, Shawn Flanagan

|Jun 26, 2024
The Impact of Dimitrios P. Kontoyiannis on Mucormycosis Research.

Russell E Lewis

|Apr 17, 2024
Triazole antifungal drug interactions-practical considerations for excellent prescribing.

Russell Lewis, Saarah Niazi-Ali, Andrew McIvor

|Dec 11, 2023
Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes.

Takahiro Matsuo, Sebastian Wurster, Ying Jiang

Pageof 4

Frequent Collaborators

3 joint publications

Paul E Verweij

3 joint publications

Oliver A Cornely

3 joint publications

Claudia Sassi

3 joint publications

Dimitrios P Kontoyiannis